-
EP3068405
European procedure
Extract from the Register of European Patents
EP About this file: EP3068405
| EP3068405 - PYRROLO [1,2,F][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.03.2020 Database last updated on 16.07.2024 | |
| Former | The patent has been granted Status updated on 29.03.2019 | ||
| Former | Grant of patent is intended Status updated on 03.01.2019 | ||
| Former | Examination is in progress Status updated on 29.11.2018 | ||
| Former | Grant of patent is intended Status updated on 10.07.2018 | ||
| Former | Examination is in progress Status updated on 13.06.2018 | ||
| Former | Grant of patent is intended Status updated on 27.02.2018 | ||
| Former | Examination is in progress Status updated on 07.07.2017 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 / US | [2016/38] | Inventor(s) | 01 /
CLARKE, Michael O'neil, Hanrahan C/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 / US | 02 /
DOERFFLER, Edward C/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 / US | 03 /
MACKMAN, Richard, L. C/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 / US | 04 /
SIEGEL, Dustin C/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 / US | [2019/18] |
| Former [2016/38] | 01 /
CLARKE, Michael O'neil, Hanrahan c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404 / US | ||
| 02 /
DOERFFLER, Edward c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404 / US | |||
| 03 /
MACKMAN, Richard, L. c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404 / US | |||
| 04 /
SIEGEL, Dustin c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404 / US | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2016/38] | Application number, filing date | 14806123.7 | 06.11.2014 | [2016/38] | WO2014US64412 | Priority number, date | US201361902544P | 11.11.2013 Original published format: US 201361902544 P | [2016/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015069939 | Date: | 14.05.2015 | Language: | EN | [2015/19] | Type: | A1 Application with search report | No.: | EP3068405 | Date: | 21.09.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.05.2015 takes the place of the publication of the European patent application. | [2016/38] | Type: | B1 Patent specification | No.: | EP3068405 | Date: | 01.05.2019 | Language: | EN | [2019/18] | Search report(s) | International search report - published on: | EP | 14.05.2015 | Classification | IPC: | C07D487/04, A61K31/16, A61P31/14, C07H7/06, A61K31/706 | [2018/09] | CPC: |
C07D487/04 (EP,EA,KR,US);
A61K31/706 (EA);
A61K31/16 (EA);
A61K31/407 (KR);
A61K31/53 (KR);
A61P31/14 (EA);
A61P31/16 (EP,US);
C07D405/04 (EP,KR,US);
C07D405/14 (EP,KR,US);
|
| Former IPC [2016/38] | A61K31/706, A61K31/16, C07D487/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/38] | Extension states | BA | 03.06.2016 | ME | 03.06.2016 | Title | German: | PYRROLO[1,2-F][1,2,4]TRIAZINE FÜR DIE BEHANDLUNG VON RESPIRATORY SYNCITIAL VIRUS (RSV)-INFEKTIONEN | [2018/09] | English: | PYRROLO [1,2,F][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | [2016/38] | French: | PYRROLO[1,2-F][1,2,4]TRIAZINES UTILES POUR TRAITER D'INFECTIONS PAR VIRUS RESPIRATOIRE SYNCYTIAL | [2018/09] |
| Former [2016/38] | PYRROLO[1,2,F][1,2,4]TRIAZIN ZUR BEHANDLUNG VON RESPIRATORISCHEN SYNZYTIALVIRUSINFEKTIONEN | ||
| Former [2016/38] | PYRROLO [1,2,F][1,2,4]TRIAZINES UTILES POUR LE TRAITEMENT D'INFECTIONS PAR LE VIRUS RESPIRATOIRE SYNCYTIAL | Entry into regional phase | 03.06.2016 | National basic fee paid | 03.06.2016 | Designation fee(s) paid | 03.06.2016 | Examination fee paid | Examination procedure | 03.06.2016 | Amendment by applicant (claims and/or description) | 03.06.2016 | Examination requested [2016/38] | 10.07.2017 | Despatch of a communication from the examining division (Time limit: M04) | 10.11.2017 | Reply to a communication from the examining division | 28.02.2018 | Communication of intention to grant the patent | 13.06.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 11.07.2018 | Communication of intention to grant the patent | 13.11.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 04.01.2019 | Communication of intention to grant the patent | 20.03.2019 | Fee for grant paid | 20.03.2019 | Fee for publishing/printing paid | 20.03.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP18209267.6 / EP3505173 | EP22182880.9 | Opposition(s) | 04.02.2020 | No opposition filed within time limit [2020/15] | Fees paid | Renewal fee | 28.11.2016 | Renewal fee patent year 03 | 27.11.2017 | Renewal fee patent year 04 | 27.11.2018 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 01.05.2019 | MC | 01.05.2019 | MK | 01.05.2019 | MT | 01.05.2019 | RS | 01.05.2019 | SM | 01.05.2019 | [2022/31] |
| Former [2021/34] | AL | 01.05.2019 | |
| MC | 01.05.2019 | ||
| MT | 01.05.2019 | ||
| RS | 01.05.2019 | ||
| SM | 01.05.2019 | ||
| Former [2020/36] | AL | 01.05.2019 | |
| MC | 01.05.2019 | ||
| RS | 01.05.2019 | ||
| SM | 01.05.2019 | ||
| Former [2020/14] | AL | 01.05.2019 | |
| RS | 01.05.2019 | ||
| SM | 01.05.2019 | ||
| Former [2019/50] | AL | 01.05.2019 | |
| RS | 01.05.2019 | Cited in | International search | [Y]WO0232920 (PHARMASSET LTD [US], et al) [Y] 1-43* example 58; claim - *; | [Y]WO2012012776 (GILEAD SCIENCES INC [US], et al) [Y] 1-43 * page 138, line 10 - page 145, line 27; example -; claim - *; | [Y]WO2012037038 (GILEAD SCIENCES INC [US], et al) [Y] 1-43 * page 110, line 6 - page 112, line 31; example -; claim - *; | [Y]WO2013138236 (GILEAD SCIENCES INC [US]) [Y] 1-43 * page 67, line 1 - page 69, line 7; example -; claim - * |